American Century Companies’s Cogent Biosciences COGT Stock Holding History

American Century Companies's COGT Position: Q2 2026 in Review

American Century Companies increased its Cogent Biosciences (COGT) stake by 61% in Q2 2026, buying an estimated $19M and bringing the position to 1,432,957 shares worth $55.5M. The position accounts for 0.02% of the portfolio, ranked #814.

American Century Companies first reported a position in COGT in Q2 2023 and has held it in 8 quarters since. 323 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

• American Century Companies held 1,432,957 shares of Cogent Biosciences worth $55.5M as of Q2 2026.
• American Century Companies bought 542,389 Cogent Biosciences shares in Q2 2026, an estimated $19M.
• Cogent Biosciences made up 0.02% of American Century Companies's portfolio in Q2 2026, its #814 holding.
• American Century Companies first reported a position in Cogent Biosciences in Q2 2023 and has held it in 8 quarters since.
• 323 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.